Online tools intended to make health care purchasing resemble “consumerism” have had little effect on improving transparency for patients.

Negative health consequences from costly care are referred to as financial toxicity and should be included in informed consent discussions.

More transparent pricing would allow patients and families to make better decisions, but there are limitations to how reliably it promotes efficiency and market discipline.

Fragmentation in US health care delivery streams and shortcomings in formal quality measures mean that transparency could be more useful to policymakers and regulators than patients.

This article analyzes differences in prescription drug pricing transparency practices among 3 Organisation of Economic Co-operation and Development member nations.

This article applies principlism to what a “shoppable service” model would demand of clinicians in practice.

The concept of mortal time is useful for exploring how hospice care frameworks might help nonhospice clinicians find calm in practice.

Ariel Levchenko joins Ethics Talk to discuss his article, coauthored with Scott Schweikart: “How Should Regulations Help Health Care Organizations Manage Waste?”

Ladan Karim-Nejad joins Ethics Talk to discuss her article, coauthored with Kayla Pangilinan: “How Should Responsibility for Proper Medication Disposal Be Shared?”

Lloyd Duplechan joins Ethics Talk to discuss his article: “How Health Care Organizations Can Be Stewardship Leaders.”